Hims & Hers Health, Inc. (HIMS)
Telehealth giant Hims & Hers says its customer support system was hacked
Hims & Hers, the telehealth company that sells weight-loss drugs and sexual health prescriptions, has confirmed a data breach affecting its third-party customer service platform.
Hims & Hers Expands Personalized Digital Healthcare Platform
HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.
Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to Note
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $18.78, denoting a -3.1% move from the preceding trading day.
Hims & Hers: The Reset Before The Next Inflection
Hims & Hers Health shares rallied to ~$27 after the early-March Novo deal before resetting to ~$20, still leaving the stock ~40% above prior coverage levels. Short interest remains elevated at ~83.3M shares (~40% float), while days-to-cover expanded from ~1.0 to ~3.6. Short volume intensity declined from ~62–64% during the selloff to ~45%, signaling reduced marginal short pressure.
Hims & Hers: Distressed Valuations Will Not Last For Long
Hims resolved its legal dispute with Novo Nordisk, removing a major overhang and enabling it to offer branded drugs. Valuations have not recovered to pre-lawsuit levels as persistent insider selling and changes in disclosure have weighed negatively on sentiment. Consensus underestimates the inherent story in Hims emanating from growth in subscribers, sustainability and penetration in new products & markets.
HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now?
Hims & Hers and Doximity are taking different paths in digital health, but which stock offers stronger upside now? Let's dive in.
Why Is Hims & Hers Health (HIMS) Up 38% Since Last Earnings Report?
Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock?
Hims & Hers Expands Integrated Digital Healthcare Ecosystem
HIMS builds a seamless digital healthcare ecosystem, expanding into diagnostics, global markets and specialty care to reshape access and delivery.
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $23.15, indicating a -7.33% shift from the previous trading day.
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market
Hims & Hers Health, Inc. (HIMS) closed at $23.84 in the latest trading session, marking a -7.88% move from the prior day.
Stock Market Today, March 12: Hims and Hers Health Drops After Rally Sparks Profit Taking
Expand NYSE: HIMS Hims & Hers Health Today's Change (-7.75%) $-2.00 Current Price $23.88 Key Data Points Market Cap $5.9B Day's Range $23.77 - $27.20 52wk Range $13.74 - $70.43 Volume 2.1M Avg Vol 30M Gross Margin 60.86%
